Sun Pharmaceutical Industries share price
Sun Pharmaceutical Industries Ltd. · NSE: SUNPHARMA · Healthcare
Price, one year
Price range
- Open
- ₹1,757.40
- High
- ₹1,765.40
- Low
- ₹1,738.20
- Previous close
- ₹1,758.00
- Volume
- 4.6 L
- Market cap
- ₹4,17,580 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 34.9
- Price to book
- 5.0
- Return on equity
- 14.5%
- EPS (TTM)
- ₹50.40
- Book value / share
- ₹348.31
- Debt to equity
- 0.05
- Revenue (TTM)
- ₹59,911 Cr
- Net profit (TTM)
- ₹12,096 Cr
- Sales growth, YoY
- +10.5%
- Profit growth, YoY
- +27.0%
- Operating margin
- 29.8%
- Net margin
- 20.2%
- Sales CAGR, 3 years
- +10.0%
- Profit CAGR, 3 years
- +10.7%
- Promoter holding
- 52.68%
- Promoter shares pledged
- 0.01%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 54.48 | 54.48 | 52.68 |
| Foreign institutions | 15.93 | 14.53 | 14.36 |
| Domestic institutions | 21.11 | 22.18 | 22.27 |
| Mutual funds | 11.96 | 12.84 | 13.01 |
| Retail and others | 5.31 | 5.48 | 6.71 |
| Promoter pledge | 1.42 | 1.65 | 0.01 |
Futures and options
22 Oct 2026- Lot size
- 350
- Put-call ratio (OI)
- 0.79
- Max pain
- ₹1,780.00
- Highest call OI strike
- 1,760.00
- Highest put OI strike
- 1,780.00
- ATM implied volatility
- 23.2% IV rank 56
- Futures basis
- −0.24%
- Rollover
- 44.5%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 22 Oct | Long buildup | +0.85% | +1.88% |
| 21 Oct | Short buildup | −0.25% | +0.13% |
| 19 Oct | Long unwinding | −0.88% | −0.03% |
| 16 Oct | Short buildup | −0.33% | +0.72% |
| 15 Oct | Short covering | +1.21% | −0.12% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 31 Jul 2026. results: 30 Oct 2026.
- 20 Oct 2026 · Press releasePress ReleaseSun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 20, 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Divi's LaboratoriesDIVISLAB | ₹8,881.00 | −3.07% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,487.80 | −2.76% |
| Zydus LifesciencesZYDUSLIFE | ₹1,124.80 | −0.90% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,584.50 | −0.26% |
| CiplaCIPLA | ₹1,319.30 | −0.87% |
| Laurus LabsLAURUSLABS | ₹1,943.10 | −2.97% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,226.70 | −0.99% |
| Mankind PharmaMANKIND | ₹2,228.10 | −2.09% |
| Aurobindo PharmaAUROPHARMA | ₹1,557.50 | −3.31% |
| LupinLUPIN | ₹1,906.60 | −0.80% |
Frequently asked questions
What is the share price of Sun Pharmaceutical Industries today?
Sun Pharmaceutical Industries (NSE: SUNPHARMA) was at ₹1,740.40 on 23 Oct 2026, a change of −1.00% from the previous close.
What are the 52-week high and low of Sun Pharmaceutical Industries?
Over the last 52 weeks Sun Pharmaceutical Industries traded between ₹1,583.70 and ₹2,046.90 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Sun Pharmaceutical Industries?
About ₹4,17,580 Cr at the latest price, with a P/E of 34.9, a price-to-book of 5.0, a return on equity of 14.5%. Ratios use the company's latest reported results.
Who owns Sun Pharmaceutical Industries shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 52.68%, foreign institutions 14.36%, domestic institutions 22.27%.
Is Sun Pharmaceutical Industries traded in futures and options?
Yes, SUNPHARMA is in NSE's futures and options segment. The lot size is 350 shares.
Which sector and indices does Sun Pharmaceutical Industries belong to?
NSE classifies Sun Pharmaceutical Industries under Healthcare; it is a member of Nifty 50, Nifty 100, Nifty 500.
Follow Sun Pharmaceutical Industries with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Get started free